FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:38-47 January 6, 1994 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The dramatic hemorrhages, the effect of the disease on history through its presence in Queen Victoria's descendants, and the devastating role of therapeutic concentrates in the transmission of the acquired immunodeficiency syndrome (AIDS) have made hemophilia A the object of great medical, scientific, and public interest. The commonest hereditary coagulation disorder and a disease without ethnic or geographic limitations, its incidence approaches 20 per 100,000 male births^1,2,3. John Conrad Otto emphasized its inheritance as an X-linked disorder in his 1803 description of the disease in a New Hampshire family: "males only are subject to this strong affection . . . . . [Full Text of this Article]

The Role of Factor VIII in Blood Coagulation

The Structure and Function of Factor VIII

Molecular Genetics of Hemophilia A

Clinical Presentation

Factor VIII Replacement Therapy

Clinical Management

Genetic Counseling and Prenatal Diagnosis

The Future

Source Information

From the Holland Laboratory, American Red Cross Biomedical Services, 15601 Crabbs Branch Way, Rockville, MD 20855, where reprint requests should be addressed to Dr. Hoyer.

References

Related Letters:

Hemophilia A
Pierce G. F., Rosner F.
Extract | Full Text  
N Engl J Med 1994; 330:1617, Jun 2, 1994. Correspondence

This article has been cited by other articles:

• Lacroix-Desmazes, S., Navarrete, A.-M., Andre, S., Bayry, J., Kaveri, S. V., Dasgupta, S. (2008). Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood 112: 240-249 [Abstract] [Full Text]  
• Shen, B. W., Spiegel, P. C., Chang, C.-H., Huh, J.-W., Lee, J.-S., Kim, J., Kim, Y.-H., Stoddard, B. L. (2008). The tertiary structure and domain organization of coagulation factor VIII. Blood 111: 1240-1247 [Abstract] [Full Text]  
• Ohmori, T., Mimuro, J., Takano, K., Madoiwa, S., Kashiwakura, Y., Ishiwata, A., Niimura, M., Mitomo, K., Tabata, T., Hasegawa, M., Ozawa, K., Sakata, Y. (2006). Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib{alpha} promoter: in vivo model for platelet-targeting gene therapy. FASEB J. 20: 1522-1524 [Abstract] [Full Text]  
• Mackman, N. (2005). Tissue-Specific Hemostasis in Mice. Arterioscler. Thromb. Vasc. Bio. 25: 2273-2281 [Abstract] [Full Text]  
• Kang, Y., Xie, L., Tran, D. T., Stein, C. S., Hickey, M., Davidson, B. L., McCray, P. B. Jr (2005). Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Blood 106: 1552-1558 [Abstract] [Full Text]  
• Ghosh, N., Marotta, P. J., McAlister, V. C. (2005). Correction of Factor XI Deficiency by Liver Transplantation. NEJM 352: 2357-2358 [Full Text]  
• Scott, D. W., Ananyeva, N. M. (2004). Mutagenesis lowers factor VIII immunogenicity. Blood 104: 598-599 [Full Text]  
• Benndorf, G., Kim, D. M., Menneking, H., Klein, M. (2004). Endovascular Management of a Mandibular Arteriovenous Malformation in a Patient with Severe Hemophilia A. Am. J. Neuroradiol. 25: 614-617 [Abstract] [Full Text]  
• Burke, W. (2003). Genomics as a Probe for Disease Biology. NEJM 349: 969-974 [Full Text]  
• Hockin, M. F., Jones, K. C., Everse, S. J., Mann, K. G. (2002). A Model for the Stoichiometric Regulation of Blood Coagulation. J. Biol. Chem. 277: 18322-18333 [Abstract] [Full Text]  
• van den Brink, E. N., Bril, W. S., Turenhout, E. A. M., Zuurveld, M., Bovenschen, N., Peters, M., Yee, T. T., Mertens, K., Lewis, D. A., Ortel, T. L., Lollar, P., Scandella, D., Voorberg, J. (2002). Two classes of germline genes both derived from the VH1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII. Blood 99: 2828-2834 [Abstract] [Full Text]  
• Butenas, S., Brummel, K. E., Branda, R. F., Paradis, S. G., Mann, K. G. (2002). Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99: 923-930 [Abstract] [Full Text]  
• Lin, Y., Chang, L., Solovey, A., Healey, J. F., Lollar, P., Hebbel, R. P. (2002). Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99: 457-462 [Abstract] [Full Text]  
• Mannucci, P. M. (2002). Ham-Wasserman Lecture : Hemophilia and Related Bleeding Disorders: A Story of Dismay and Success. ASH Education Book 2002: 1-9 [Abstract] [Full Text]  
• Aledort, L. M., Mariani, G., Kroner, B. L., Brackmann, H. H., Punch, J. D., Merion, R. M., Turcotte, J. G., Mannucci, P. M., Tuddenham, E. D.G. (2001). Hemophilia. NEJM 345: 1066-1067 [Full Text]  
• Minhas, H L, Giangrande, P L F (2001). Presentation of severe haemophilia--A role for accident and emergency doctors?. Emerg. Med. J. 18: 246-249 [Abstract] [Full Text]  
• Mannucci, P. M., Tuddenham, E. G.D. (2001). The Hemophilias -- From Royal Genes to Gene Therapy. NEJM 344: 1773-1779 [Full Text]  
• Rossi, G., Sarkar, J., Scandella, D. (2001). Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A. Blood 97: 2750-2757 [Abstract] [Full Text]  
• van den Brink, E. N., Turenhout, E. A. M., Bovenschen, N., Heijnen, B. G. A. D. H., Mertens, K., Peters, M., Voorberg, J. (2001). Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII. Blood 97: 966-972 [Abstract] [Full Text]  
• Gallo-Penn, A. M., Shirley, P. S., Andrews, J. L., Tinlin, S., Webster, S., Cameron, C., Hough, C., Notley, C., Lillicrap, D., Kaleko, M., Connelly, S. (2001). Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. Blood 97: 107-113 [Abstract] [Full Text]  
• Weitz, J. I., Hirsh, J. (2001). New Anticoagulant Drugs. Chest 119: 95S-107S [Full Text]  
• van den Brink, E. N., Turenhout, E. A. M., Bank, C. M. C., Fijnvandraat, K., Peters, M., Voorberg, J. (2000). Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain. Blood 96: 540-545 [Abstract] [Full Text]  
• Al-Jarallah, A., Al-Rifai, M. T., Riela, A. R., Roach, E. S. (2000). Nontraumatic Brain Hemorrhage in Children: Etiology and Presentation. J Child Neurol 15: 284-289 [Abstract]  
• Qian, J., Collins, M., Sharpe, A. H., Hoyer, L. W. (2000). Prevention and treatment of factor VIII inhibitors in murine hemophilia A. Blood 95: 1324-1329 [Abstract] [Full Text]  
• Balague, C., Zhou, J., Dai, Y., Alemany, R., Josephs, S. F., Andreason, G., Hariharan, M., Sethi, E., Prokopenko, E., Jan, H.-y., Lou, Y.-C., Hubert-Leslie, D., Ruiz, L., Zhang, W.-W. (2000). Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95: 820-828 [Abstract] [Full Text]  
• van den Brink, E. N., Turenhout, E. A. M., Davies, J., Bovenschen, N., Fijnvandraat, K., Ouwehand, W. H., Peters, M., Voorberg, J. (2000). Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. Blood 95: 558-563 [Abstract] [Full Text]  
• Hedner, U., Ginsburg, D., Lusher, J. M., High, K. A. (2000). Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia. ASH Education Book 2000: 241-265 [Abstract] [Full Text]  
• Butenas, S., van't Veer, C., Mann, K. G. (1999). "Normal" Thrombin Generation. Blood 94: 2169-2178 [Abstract] [Full Text]  
• Connelly, S., Andrews, J. L., Gallo, A. M., Kayda, D. B., Qian, J., Hoyer, L., Kadan, M. J., Gorziglia, M. I., Trapnell, B. C., McClelland, A., Kaleko, M. (1998). Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene Therapy. Blood 91: 3273-3281 [Abstract] [Full Text]  
• Fijnvandraat, K., Celie, P. H.N., Turenhout, E. A.M., ten Cate, J. W., van Mourik, J. A., Mertens, K., Peters, M., Voorberg, J. (1998). A Human Alloantibody Interferes With Binding of Factor IXa to the Factor VIII Light Chain. Blood 91: 2347-2352 [Abstract] [Full Text]  
• Ewenstein, B. M., Van Cott, E. (1998). Case 6-1998- A Six-Year-Old Boy with Both Pain and a Bloody Effusion in the Right Hip. NEJM 338: 532-539 [Full Text]  
• Carmeliet, P., Collen, D. (1997). Molecular analysis of blood vessel formation and disease. Am. J. Physiol. Heart Circ. Physiol. 273: H2091-H2104 [Abstract] [Full Text]  
• van `t Veer, C., Golden, N. J., Kalafatis, M., Simioni, P., Bertina, R. M., Mann, K. G. (1997). An In Vitro Analysis of the Combination of Hemophilia A and Factor VLEIDEN. Blood 90: 3067-3072 [Abstract] [Full Text]  
• Fijnvandraat, K., Turenhout, E. A.M., van den Brink, E. N., ten Cate, J. W., van Mourik, J. A., Peters, M., Voorberg, J. (1997). The Missense Mutation Arg593 right-arrow Cys Is Related to Antibody Formation in a Patient With Mild Hemophilia A. Blood 89: 4371-4377 [Abstract] [Full Text]  
• Pierce, G. F., Rosner, F. (1994). Hemophilia A. NEJM 330: 1617-1617 [Full Text]